HKU Biomed Entrepreneurship Talk Series

Our school has launched the ‘HKU Biomed Entrepreneurship Talk Series’ which aims to stimulate academic’s interest in translating their basic innovations to applications through inviting academics/entrepreneurs to share their experience with startups.

Date: 3 November 2021 (Wednesday)

Time: 4:00 – 5:30pm

Venue: Seminar Room 1, G/F Laboratory Block, 21 Sassoon Road, Pokfulam, Hong Kong

Online Registration*: https://hku.au1.qualtrics.com/jfe/form/SV_0wa9mGCR30jP2lg

* Please read the Personal Information Collection Statement before you register. 

Title: Transforming a Biotech Startup to High-Growth Company during the COVID-19 Pandemic

Speaker: Ricky Yin-To Chiu, Founder & CEO, PHASE Scientific

Biography: 

Ricky Chiu, is the CEO and founder of PHASE Scientific, a fast-growing biotechnology company that has developed a game-changing sample preparation technology. The Company’s current focuses include cancer liquid biopsy and point-of-care tests for infectious diseases. During the COVID-19 pandemic, the Company has developed a full-range of COVID-19 testing products and services, including PCR and rapid tests to support Hong Kong and other regions against the pandemic.

Ricky have been the principal of multiple grants, including grants from the US National Institutes of Health, National Science Foundation, and Bill & Melinda Gates Foundation. It currently has 180 employees, and operations in Hong Kong (HQ), the U.S.A., and Mainland China. 

Born and raised in Hong Kong, Ricky pursued his Ph.D. in bioengineering at UCLA. 

Ricky is also an adjunct associate professor at CUHK School of Biomedical Sciences. 

Abstract: 

Dr. Ricky Chiu and his team at PHASE Scientific foresaw a potential global disaster in the making early last year, and since then worked relentlessly to develop COVID-19 diagnostics using their proprietary technology. To date PHASE has become government’s recognized COVID-19 testing institute, the only Asian company to be on the US FDA recommended list for RNA extraction platform, as well as the first Greater China company to obtain US FDA EUA for the INDICAID rapid antigen test. Their products are now sold in over 30 countries and staff grows 4 folds in a short time. During this talk, Dr. Chiu will share the ups and downs during his entrepreneurial journey, lessons learnt in building a high-growth business, and his thoughts on the future of biotech industry in Hong Kong.

ALL ARE WELCOME

Should you have any enquiries, please feel free to contact Mr Ivan Li at 3917-9262.